Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Bengaluru: The Karnataka government has initiated prosecution against Paschim Banga Pharmaceuticals after five women died following C-section deliveries in Ballari district, where they were administered the company’s IV fluid.

Health Minister Dinesh Gundu Rao told the Assembly on Thursday that the government is seeking compensation for the bereaved families. “A child has lost its mother. We can’t let this go. Though compensation cannot bring back lives, the company must be held liable,” Rao said.

The deaths occurred at Ballari District Hospital in November. A medical panel from Rajiv Gandhi University of Health Sciences has ruled out medical negligence, pointing to the Ringer’s Lactate solution manufactured by Paschim Banga as the suspected cause.

Multiple batches of the IV fluid failed quality tests in Karnataka laboratories. Drug Controllers in five districts – Shivamogga, Chikkamagaluru, Haveri, Bengaluru, and Gadag – have filed complaints in jurisdictional courts between December 7-9.

In Shivamogga, charges have been filed under Sections 18(a)(i) and 27(d) of the Drugs and Cosmetics Act. The offences carry imprisonment between one to two years and a minimum fine of Rs 20,000 for manufacturing and selling substandard or spurious drugs.

Related Posts

Puresta launches EVERQ, AI-powered skin-health platform

Puresta Lifestyle Private Limited announced the launch of EVERQ, an AI-powered skin-health platform designed to bring skin assessment, dermatologist consultations, personalised treatment and ongoing skincare together in one connected journey.…

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell interventions that have not been approved for routine clinical use, including those offered for autism, should not be provided as routine, standard or commercial clinical services, the advisory…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre

US FDA launches expedited IND Pilot, begins accepting applications

US FDA launches expedited IND Pilot, begins accepting applications

PIL in SC seeks time-bound probe, stringent action against fake drug networks

PIL in SC seeks time-bound probe, stringent action against fake drug networks

Ghaziabad: Fake supplement racket busted, 5 held

Ghaziabad: Fake supplement racket busted, 5 held

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records